The Korea Institute of Machinery and Materials had developed a system that filters fine dust in the white smoke emitted from thermoelectric power plants and waste incinerating facilities through simultaneous cooling and absorption.
The condensable fine dust particles, which are emitted as gas at high temperatures, are turned into solid particles as they cool down.
The research team collected smoke of over 100 degrees Celsius, cooled it down to close to room temperature, turned the gas into a liquid, and filtered the moisture to eliminate the fine dust particles.
The research team used a simple cooling system to filter as many condensable fine dust particles as possible from the white smoke and then use additives to absorb the moisture.
The method allowed the research team to filter 70 percent of moisture and 80 percent of fine dust before spraying moisture absorbers one more time to dry off the water.
As a result, up to 85 percent of moisture and fine dust were filtered.


FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Drug pollution in water is making salmon take more risks – new research
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
How America courted increasingly destructive wildfires − and what that means for protecting homes today
How to create a thriving forest, not box-checking ‘tree cover’
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
We combed through old botanical surveys to track how plants on Australia’s islands are changing
Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
What’s so special about Ukraine’s minerals? A geologist explains
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



